Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Krempa currently holds 96,829 shares of Eton Pharmaceuticals, Inc. (ETON), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Krempa has been a net neutral trader of ETON stock. They have purchased $0 and sold $0 worth of shares.
David Krempa's most recent insider trade was on Jun 26, 2026, when they sold 10,000 shares at $0.00 per share.
David Krempa serves as Executive at Eton Pharmaceuticals, Inc. (ETON). They have executed 4 insider transactions totaling $0 over their tenure at the company.
David Krempa holds the position of Executive at Eton Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
David Krempa has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by David Krempa was on Dec 12, 2025, when they sold $106.5K worth of ETON shares. This transaction involved 6,264 shares at $17.00 per share.
David Krempa currently owns 96,829 shares of Eton Pharmaceuticals, Inc. (ETON), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Krempa's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Krempa has 4 Form 4 filings on record as an insider at Eton Pharmaceuticals, Inc..
Set alerts for David Krempa and 40,000+ other insiders.